Follow
Martine Bagot
Martine Bagot
Université Paris 7
Verified email at aphp.fr
Title
Cited by
Cited by
Year
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).
H Bocquet, M Bagot, JC Roujeau
Seminars in cutaneous medicine and surgery 15 (4), 250-257, 1996
12461996
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United …
EA Olsen, S Whittaker, YH Kim, M Duvic, HM Prince, SR Lessin, GS Wood, ...
Journal of Clinical Oncology 29 (18), 2598, 2011
6482011
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
HM Prince, YH Kim, SM Horwitz, R Dummer, J Scarisbrick, P Quaglino, ...
The Lancet 390 (10094), 555-566, 2017
5482017
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ...
The lancet oncology 19 (9), 1192-1204, 2018
5102018
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome–Update 2017
F Trautinger, J Eder, C Assaf, M Bagot, A Cozzio, R Dummer, R Gniadecki, ...
European journal of cancer 77, 57-74, 2017
5002017
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell …
NJ Senff, EM Noordijk, YH Kim, M Bagot, E Berti, L Cerroni, R Dummer, ...
Blood, The Journal of the American Society of Hematology 112 (5), 1600-1609, 2008
4942008
Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells
A Nassif, A Bensussan, L Boumsell, A Deniaud, H Moslehi, P Wolkenstein, ...
Journal of allergy and clinical immunology 114 (5), 1209-1215, 2004
4842004
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary …
W Kempf, K Pfaltz, MH Vermeer, A Cozzio, PL Ortiz-Romero, M Bagot, ...
Blood, The Journal of the American Society of Hematology 118 (15), 4024-4035, 2011
4612011
Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and …
JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ...
Journal of Clinical Oncology 33 (32), 3766, 2015
4152015
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis
A Nassif, A Bensussan, N Bachot, M Bagot, L Boumsell, JC Roujeau, ...
Journal of Investigative Dermatology 118 (4), 728-733, 2002
3722002
Increasing comorbidities suggest that atopic dermatitis is a systemic disorder
PM Brunner, JI Silverberg, E Guttman-Yassky, AS Paller, K Kabashima, ...
Journal of Investigative Dermatology 137 (1), 18-25, 2017
3662017
Blastic NK-Cell Lymphomas (Agranular CD4+ CD56+ Hematodermic Neoplasms) A Review
T Petrella, M Bagot, R Willemze, M Beylot-Barry, B Vergier, M Delaunay, ...
American journal of clinical pathology 123 (5), 662-675, 2005
3662005
Vascular skin symptoms in COVID-19: a French observational study
JD Bouaziz, T Duong, M Jachiet, C Velter, P Lestang, C Cassius, ...
J Eur Acad Dermatol Venereol 34 (9), e451-e452, 2020
3652020
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases
B Vergier, A de Muret, M Beylot-Barry, L Vaillant, D Ekouevi, G Chene, ...
Blood, The Journal of the American Society of Hematology 95 (7), 2212-2218, 2000
3382000
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature
E Puzenat, V Bronsard, S Prey, PA Gourraud, S Aractingi, M Bagot, ...
Journal of the European Academy of Dermatology and Venereology 24, 10-16, 2010
3222010
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases
F Grange, M Beylot-Barry, P Courville, E Maubec, M Bagot, B Vergier, ...
Archives of dermatology 143 (9), 1144-1150, 2007
3162007
Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study
F Grange, MW Bekkenk, J Wechsler, C Meijer, L Cerroni, M Bernengo, ...
Journal of clinical oncology 19 (16), 3602-3610, 2001
3132001
IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro
JD Bouaziz, S Calbo, M Maho‐Vaillant, A Saussine, M Bagot, ...
European journal of immunology 40 (10), 2686-2691, 2010
3032010
Open trial of ciclosporin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis
L Valeyrie‐Allanore, P Wolkenstein, L Brochard, N Ortonne, B Maître, ...
British Journal of Dermatology 163 (4), 847-853, 2010
2972010
Nonhepatosplenic γδ T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization
B Arnulf, C Copie-Bergman, MH Delfau-Larue, A Lavergne-Slove, J Bosq, ...
Blood, The Journal of the American Society of Hematology 91 (5), 1723-1731, 1998
2711998
The system can't perform the operation now. Try again later.
Articles 1–20